⌘K
t
CVS Group plc announced on 17 November 2025 that its Chief Financial Officer, Robin Alfonso, purchased 870 ordinary shares in the company at 1,146.99 pence per share on the same date via the London Stock Exchange - AIM. Following this transaction, Mr. Alfonso's total interest is 25,247 ordinary shares, representing 0.035% of the total voting rights.
| Date | 17 Nov 2025 |
| Time | 16:31:28 |
| Category | Director/PDMR dealings |
| ID | 8623H |
17 November 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 17 November 2025 that Robin Alfonso, Chief Financial Officer of the Company, purchased a total of 870 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.
As a result, Robin Alfonso's total interest in the Company, including all persons closely associated, is now 25,247 Ordinary Shares, representing 0.035% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR) [email protected]
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Robin Alfonso |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
PDMR (CFO) |
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
CVS Group plc |
||||
|
b)
|
LEI
|
213800J41XDQ2NX48O05 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.2 pence each
GB00B2863827
|
||||
|
b)
|
Nature of the transaction
|
On-market purchase |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction |
||||
|
e)
|
Date of the transaction
|
17 November 2025 |
||||
|
f)
|
Place of the transaction
|
London Stock Exchange - AIM (XLON) |
||||